PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 6791010

Solid solutions as long-acting naltrexone delivery systems.

J L Olsen
View original source ↗Export metadata ↓

Abstract

Solid solutions and solid dispersions have been used both to increase and to decrease solubility. Solid solutions may extend the release of naltrexone depending upon composition and production methods. Several combinations of naltrexone and cholesterol esters were prepared and evaluated. These combinations did prolong release of the drug in some cases, but none acceptably long enough. Preparation of these solutions and dispersions involved compression and heat as well as solvent mixing. Drug release from particles is dependent upon surface area, composition, and method of preparation. Suspendable, injectable particles can be produced which will give acceptable release rates. The preparation and evaluation are complex and will require much more research effort.

Explore related subjects

AnalgesicsAnimalsChemistry, PharmaceuticalDrug ImplantsNaloxoneNaltrexoneRatsSolubilityJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J L Olsen. 1981. Solid solutions as long-acting naltrexone delivery systems.. https://pubmed.ncbi.nlm.nih.gov/6791010/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1995

The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation.

OBJECTIVE: To perform a systematic review of studies evaluating the effectiveness of the World Health Organization (WHO) analgesic ladder as an intervention for cancer pain management. DATA SOURCES: Systematic search of MEDLINE from 1982 to 1995, hand search of textbooks and meeting proceedings, reference lists, and direct contact with authors. STUDY SELECTION: Studies of any methodological design were included if they evaluated patients with cancer pain treated according to the WHO analgesic ladder and if the studies provided enough information to estimate the proportion of patients who achieved adequate analgesia with the use of the ladder. The strength of the evidence provided by each study was assessed separately by both authors using current concepts. DATA EXTRACTION: From the hard copy of each study report, the first author's name, publication year, study design, number of dropouts per study, and proportion of patients with adequate analgesia in each study were extracted. DATA SYNTHESIS: Eight studies purporting to evaluate the effectiveness of the WHO ladder were included in the review. Meta-analysis was not performed because the studies were case series with no control groups. The studies had other limitation: none provided information on the conditions in which pain was assessed; two were retrospective; one had short follow-up periods; three had high withdrawal rates; and one had variable follow-up periods. Analgesia was adequate in 69% to 100% of patients analyzed in the studies. CONCLUSIONS: The studies available provide valuable information on the course of cancer pain and its treatment. However, the evidence they provide is insufficient to estimate confidently the effectiveness of the WHO analgesic ladder for the management of cancer pain. Until results from carefully designed controlled trials are available, it would be inappropriate to judge the performance of clinicians, programs, and institutions or to design policies based on such evidence.

Analgesics↗
PubMed1995

Selective opioid inhibition of small nociceptive neurons.

Opioid analgesia, the selective suppression of pain without effects on other sensations, also distinguishes between different types of pain: severe, persistent pain is potently inhibited by opioids, but they fail to cohceal the sensation of a pinprick. The cellular basis for this specificity was analyzed by means of patch-clamp experiments performed on fluorescently labeled nociceptive neurons (nociceptors) that innervate rat tooth pulp. Activation of the mu opioid receptor inhibited calcium channels on almost all small nociceptors but had minimal effect on large nociceptors. Somatostatin had the opposite specificity, preferentially inhibiting calcium channels on the large cells. Because persistent pain is mediated by slow-conducting, small nociceptors, opioids are thus likely to inhibit neurotransmitter release only at those primary synapses specialized for persistent pain.

Analgesics↗